Myelin Interface Restoration Therapy
🧪 Overview
The myelin-axon interface shows specific vulnerability in AD, with subcellular proteomics revealing disrupted protein networks at this critical junction. Therapeutic restoration of myelin interface integrity through oligodendrocyte precursor cell activation and maturation factor enhancement could prevent axonal degeneration and preserve cognitive function.
Debate provenance: derived from debate `sess_SDA-2026-04-03-gap-seaad-20260402025452` on question: What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data? Use Allen Brain Cell Atlas evidence. Identify mechanisms of cell-type-specific vulnerability in AD pathology.. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Interface, Myelin, OLIG2, Restoration, activation. Novelty signal: skeptic-discussed-with-qualified-concession.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
APOE4["APOE4"] -->|causes| myelin_breakdown["myelin breakdown"]
APOE4_1["APOE4"] -->|risk factor for| sporadic_Alzheimer_s_dise["sporadic Alzheimer's disease"]
TREM2["TREM2"] -->|regulates| chronic_inflammation["chronic inflammation"]
CD33["CD33"] -.->|inhibits| cytokine_production["cytokine production"]
CD33_2["CD33"] -->|regulates| monocyte_activation["monocyte activation"]
CD33_3["CD33"] -->|modulates| microglial_immune_respons["microglial immune responses"]
PICALM["PICALM"] -->|causes| lipid_droplet_formation["lipid droplet formation"]
PICALM_4["PICALM"] -->|associated with| microglia["microglia"]
APOE4_5["APOE4"] -->|targets| oligodendrocytes["oligodendrocytes"]
myelin_axon_interface_dis["myelin-axon interface disruption"] -->|causes| axonal_degeneration["axonal degeneration"]
oligodendrocyte_maturatio["oligodendrocyte maturation factors"] -->|regulates| myelin_integrity["myelin integrity"]
OLIG2["OLIG2"] -->|regulates| oligodendrocyte_different["oligodendrocyte differentiation"]
style APOE4 fill:#ce93d8,stroke:#333,color:#000
style myelin_breakdown fill:#4fc3f7,stroke:#333,color:#000
style APOE4_1 fill:#ce93d8,stroke:#333,color:#000
style sporadic_Alzheimer_s_dise fill:#ef5350,stroke:#333,color:#000
style TREM2 fill:#ce93d8,stroke:#333,color:#000
style chronic_inflammation fill:#4fc3f7,stroke:#333,color:#000
style CD33 fill:#ce93d8,stroke:#333,color:#000
style cytokine_production fill:#4fc3f7,stroke:#333,color:#000
style CD33_2 fill:#ce93d8,stroke:#333,color:#000
style monocyte_activation fill:#4fc3f7,stroke:#333,color:#000
style CD33_3 fill:#ce93d8,stroke:#333,color:#000
style microglial_immune_respons fill:#4fc3f7,stroke:#333,color:#000
style PICALM fill:#ce93d8,stroke:#333,color:#000
style lipid_droplet_formation fill:#4fc3f7,stroke:#333,color:#000
style PICALM_4 fill:#ce93d8,stroke:#333,color:#000
style microglia fill:#4fc3f7,stroke:#333,color:#000
style APOE4_5 fill:#ce93d8,stroke:#333,color:#000
style oligodendrocytes fill:#4fc3f7,stroke:#333,color:#000
style myelin_axon_interface_dis fill:#4fc3f7,stroke:#333,color:#000
style axonal_degeneration fill:#4fc3f7,stroke:#333,color:#000
style oligodendrocyte_maturatio fill:#4fc3f7,stroke:#333,color:#000
style myelin_integrity fill:#4fc3f7,stroke:#333,color:#000
style OLIG2 fill:#ce93d8,stroke:#333,color:#000
style oligodendrocyte_different fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — OLIG2
No curated PDB or AlphaFold mapping for OLIG2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for OLIG2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |